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Abstract 19 
Mitochondria are often regarded as the cellular powerhouses through their ability to 20 
generate ATP, the universal fuel for metabolic processes. However, in recent years 21 
mitochondria have been recognised as critical regulators of cell death, inflammation, 22 
metabolism and generation of reactive oxygen species (ROS). Thus, mitochondrial 23 
dysfunction directly promotes cell death, inflammation and oxidative stress, and 24 
alters metabolism. These are key processes in atherosclerosis and there is now 25 
evidence that mitochondrial DNA (mtDNA) damage leads to mitochondrial 26 
dysfunction and promotes atherosclerosis directly. In this review we discuss the 27 
recent evidence for and mechanisms linking mtDNA defects and atherosclerosis, and 28 
suggest areas of mitochondrial biology that are potential therapeutic targets. 29 
 30 
 31 
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Atherosclerosis- a mitochondrial disease? 33 
Despite pharmacological and surgical treatment options, atherosclerosis remains the 34 
leading cause of death in the western world. The disease affects arteries and is 35 
characterised by the formation of fatty plaques. These plaques can rupture, 36 
potentially leading to vessel occlusion and clinical manifestations such as heart 37 
attacks and strokes[1]. With such morbidity and mortality the need remains to identify 38 
the underlying disease mechanisms and to find new therapeutic targets. Recent 39 
evidence highlights a role for mtDNA damage and dysfunction in atherogenesis.  40 
 41 
The atherosclerotic plaque forms when lipid accumulates at sites of endothelial 42 
damage and dysfunction. The lipids are susceptible to oxidative modification by 43 
reactive oxygen species (ROS, see Glossary) and act as inflammatory stimuli, 44 
attracting leukocytes to the site. Monocytes therefore migrate into the developing 45 
plaque and differentiate into macrophages that engulf the oxidised lipids. 46 
Inflammatory factors released by macrophages stimulate the migration and/or 47 
proliferation of vascular smooth muscle cells (VSMCs) [1]. VSMCs are important for 48 
plaque stability, as they secrete the extra-cellular matrix that forms a fibrous cap. 49 
However, VSMC death, fibrous cap thinning and subsequent plaque vulnerability 50 
may be induced by inflammation [2].  51 
 52 
Inflammation, cell death and oxidative stress are therefore key processes driving 53 
plaque development and transition to a vulnerable plaque phenotype [3, 4]. As 54 
mitochondrial dysfunction can promote these pro-atherogenic processes, 55 
mitochondrial damage has been implicated in atherogenesis, including damage to 56 
mitochondrial DNA (mtDNA) [5]. However, the finding that mtDNA defects can 57 
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directly promote atherogenesis and plaque vulnerability has only recently been 58 
demonstrated [6]. Furthermore, emerging work has identified multiple mechanisms 59 
linking mitochondria and inflammation [7], whilst the role of the vicious circle of 60 
mtDNA damage leading to mitochondrial dysfunction and oxidative stress leading to 61 
further mtDNA damage remains under debate [8]. In this review we will discuss the 62 
recent evidence of the role and mechanisms of mtDNA damage and atherosclerosis. 63 
 64 
Mitochondrial DNA damage and atherosclerosis 65 
Mitochondria generate ATP through oxidative phosphorylation within the respiratory 66 
chain, where electron transport is coupled with the production of ATP from ADP. 67 
However, ROS are formed as a by-product of the respiratory chain making 68 
mitochondria the major source of cellular ROS [9] (Figure 1). The respiratory 69 
complexes are composed of both nuclear and mtDNA encoded subunits, meaning 70 
that their formation requires careful coordination of the two genomes [10]. 71 
Mitochondria are unique as they are the only source of DNA within a cell apart from 72 
the nucleus. The human mitochondrial genome exists as a 16569 bp loop, coding for 73 
ribosomal and transfer RNAs, in addition to 13 respiratory chain subunits [10]. 74 
However mtDNA is vulnerable to damage, partly because it lies close to the site of 75 
ROS production and also because it lacks protection by histones. It has been 76 
proposed that mtDNA damage can impair respiratory chain function, and eventually 77 
compromise cellular function promoting ageing and disease [11].  78 
 79 
mtDNA lesions are found in circulating cells and hearts of patients with coronary 80 
artery disease, suggesting that mtDNA damage may contribute towards 81 
atherosclerosis development [12, 13]. mtDNA damage is an early event in 82 
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atherogenesis [5], and recent work shows that both mtDNA damage and 83 
mitochondrial dysfunction are present in a model of atherosclerosis and metabolic 84 
syndrome [14]. However, although this study suggested that mtDNA damage 85 
promotes both atherosclerosis and the metabolic syndrome, the effects of mtDNA 86 
damage could not be separated from those of nuclear DNA damage. 87 
 88 
To directly study the effects of mtDNA lesions, recent studies have utilized mice with 89 
extensive mtDNA damage, such as the mutator mice. These mice express mtDNA 90 
polymerase with impaired proof-reading ability that introduces point mutations and 91 
deletions into mtDNA [15, 16]. The mice show an aged phenotype, with kyphosis, 92 
anaemia and weight loss. Mutator mice that were also deficient for apolipoprotein E 93 
showed that mtDNA defects promote atherosclerosis and plaque vulnerability, and 94 
can do so without any increase in ROS. In contrast, VSMC and monocyte apoptosis 95 
was increased, and monocytes showed a pro-inflammatory profile. Furthermore, 96 
mtDNA lesions were associated with high-risk atherosclerotic plaques in humans [6]. 97 
Taken together, we now have evidence that mtDNA defects can have a causal role in 98 
atherosclerosis, that the effects can be independent of oxidative stress, and that the 99 
findings may be relevant to human disease. 100 
 101 
Mechanisms of mtDNA damage 102 
Although mtDNA damage has been identified in human atherosclerotic disease, 103 
these studies did not examine the underlying cause. One possibility is that mtDNA 104 
undergoes cumulative, oxidative damage from ROS generated by the nearby 105 
respiratory chain [11] (Figure 1). This hypothesis appears plausible given that 106 
atherosclerotic risk factors are associated with increased oxidative stress. For 107 
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example, hyperglycaemia increases superoxide production whilst cigarette smoking 108 
promotes the reduction of oxygen to form ROS [17]. Interestingly mtDNA defects in 109 
circulating cells can be associated with diabetes, although a causal role could not be 110 
proven [6].  111 
 112 
Apart from oxidative damage, replication errors are another source of mtDNA 113 
defects. Lesions such as point mutations can form in early life, and undergo clonal 114 
expansion to reach a threshold level where mitochondrial function is impaired [11]. 115 
mtDNA lesions may persist as mitochondria have a reduced capacity for DNA 116 
damage repair; whilst mitochondrial base excision repair has been well described, 117 
nucleotide excision repair is lacking [10].  118 
 119 
Inflammation - a link between mitochondria and atherosclerosis 120 
Once mtDNA defects are present, they can result in decreased respiratory subunit 121 
formation, impaired mitochondrial respiration and reduced ATP content [18]. 122 
Furthermore, cellular phenotype is also altered as mtDNA defects and dysfunction 123 
result in a pro-inflammatory profile that likely promotes plaque vulnerability [6]. 124 
Thinning of the fibrous cap and increased necrotic core area (features of vulnerable 125 
plaque) were observed in apolipoprotein E deficient recipients of mutator mouse 126 
bone marrow. Isolated monocytes from mutator mice show mtDNA damage and 127 
increased release of tumour necrosis factor alpha (TNFα) and interleukin 1 (IL1β) 128 
[6]. These findings are consistent with the growing body of work identifying multiple 129 
mechanisms linking mitochondria and inflammation, a key atherogenic process. 130 
 131 
How do mitochondria regulate inflammation? 132 
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The innate immune system has developed to detect and protect against dangerous 133 
stimuli. Toll-like receptors (TLRs) are a key part of detection, and recognise a broad 134 
range of pathogen-associated and damage-associated molecular patterns (PAMPs 135 
and DAMPs). Similar to bacterial genomes, mtDNA has significant amounts of 136 
unmethylated DNA as CpG islands. Recent work has shown that mtDNA, with its 137 
inflammatory motifs, can act as a DAMP to directly activate the immune response 138 
through activation of TLR9 [19]. mtDNA can be circulating or, for example, come from 139 
damaged mitochondria that have escaped from autophagy [19, 20]. Activation of 140 
TLR9 leads to increased nuclear factor kappa beta (NFκβ) signaling and pro-141 
inflammatory cytokine expression (Figure 2). 142 
 143 
Mitochondria also regulate cytokine release by affecting post-translational 144 
modification (Figure 2). Emerging work has identified a key role for mitochondrial 145 
dysfunction in the activation of the NLRP3 inflammasome, a multi-protein complex 146 
composed of NLRP3, ASC and caspase 1. A number of stimuli may act as  147 
endogenous danger signals to activate NLRP3, such as low intracellular potassium 148 
concentration, bacterial toxins such as nigericin, and indeed cholesterol crystals [21], 149 
which may be particularly relevant in atherosclerosis. Upon activation NLRP3 150 
redistributes from the endoplasmic reticulum (ER) to co-localise with its adapter ASC 151 
at perinuclear ER-mitochondrial clusters [22]. Recently NLRP3 was shown to be 152 
recruited to mitochondria, an action mediated by the mitochondria-associated 153 
adaptor molecule MAVS [23]. Once the inflammasome is activated, active caspase 1 154 
assembles which cleaves pro-IL1β into its mature form.  155 
 156 
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Initial work linking mitochondrial dysfunction and inflammasome activation showed 157 
that the accumulation of dysfunctional, ROS-generating mitochondria activates 158 
NLRP3 [22]. Mitochondrial dysfunction also reduces mitochondrial membrane 159 
potential and increases mitochondrial permeability transition pore (MPTP) opening. 160 
mtDNA is released into the cytosol, where it directly binds with and activates the 161 
NLRP3 inflammasome [24, 25]. Mitochondria can also signal danger through 162 
cardiolipin, a lipid usually found in the inner mitochondrial membrane. In 163 
dysfunctional mitochondria cardiolipin localises to the outer mitochondrial membrane, 164 
where it recruits, binds to, and activates NRLP3 [26, 27].  165 
 166 
Mitochondrial dysfunction also promotes inflammasome activation through altered 167 
levels of the coenzyme nicotinamide adenine dinucleotide (NAD+). The ratio of 168 
NAD/NADH indicates cellular nutrient and energy status, with an increased ratio in 169 
starvation, and decreased levels with mitochondrial dysfunction [28]. Changes in the 170 
ratio of NAD/NADH are sensed by the NAD-dependent enzymes deacetylases, 171 
sirtuins. Decreased NAD+ concentration during mitochondrial dysfunction leads to 172 
reduced Sirtuin 2 activity and the accumulation of acetylated α-tubulin at the 173 
perinuclear region. The change in acetylated tubulin increases co-localisation of 174 
NLRP3 with ASC and hence inflammasome activation [28].  175 
 176 
Mitochondria are therefore a site of NRLP3 inflammasome activation, and when 177 
dysfunctional can activate NLRP3 through ROS, mtDNA release, cardiolipin and 178 
altering NAD/NADH (Figure 2). mtDNA damage may therefore result in mitochondrial 179 
dysfunction, and lead to increased IL1β through the above mechanisms to promote 180 
atherosclerosis. However, recent data highlights that IL1α is also important in 181 
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atherogenesis, and perhaps even more so than IL1β [29]. In mice deficient for low-182 
density lipoprotein receptor (LDLR), bone marrow transplantation from IL1α deficient, 183 
but not IL1β-deficient donors led to a significant reduction in atherosclerosis. IL1α is 184 
therefore an important inducer of vascular inflammation and, similar to IL1β, its 185 
secretion is increased by mitochondrial dysfunction. The dietary fatty acid oleic acid 186 
accumulates in mouse atherosclerotic plaques and selectively stimulates 187 
macrophage IL1α production. Mitochondrial uncoupling induced by oleic acid triggers 188 
intracellular calcium fluxes that activate the protease calpain. Active calpain then 189 
cleaves pro-IL1α into its mature form [29]. In contrast with IL1β secretion, oleic acid 190 
induced IL1α secretion is independent of the NLRP3 inflammasome [29]. 191 
 192 
Collectively this work suggests that mitochondrial dysfunction can promote 193 
inflammation through upregulation of cytokine expression and inflammasome-194 
dependent and -independent pathways. Metabolic stress such as cholesterol crystals 195 
and fatty acids may be sensed by mitochondria in atherogenesis, leading to an 196 
inflammatory response that drives plaque development. This response is amplified if 197 
there is underlying mtDNA damage and dysfunction.  198 
 199 
Oxidative stress, mtDNA damage and atherosclerosis  200 
Although inflammation is an important link between mtDNA damage, dysfunction and 201 
atherosclerosis, oxidative stress may also mediate the effects of mtDNA defects. As 202 
suggested in the mitochondrial/free-radical theory of ageing, a vicious cycle can exist 203 
where ROS production leads to mtDNA damage and impaired respiratory chain 204 
function; this results in increased ROS generation, fuelling the cycle [8].  205 
 206 
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The free radical theory is attractive in the setting of atherosclerosis as oxidative 207 
stress appears to be a key part of the disease. Increased ROS are present in the 208 
vessel wall at all stages of atherogenesis [30]. ROS can modify DNA, proteins and 209 
lipids, with lipid oxidation being an important event in atherogenesis [31]. Oxidative 210 
DNA damage has also been observed in VSMCs in human atherosclerotic plaques, 211 
associated with upregulation of DNA damage repair proteins [32]. Further evidence 212 
supporting the role of ROS in atherosclerosis comes from several murine models. 213 
For example, impaired anti-oxidant activity, such as decreased glutathione 214 
peroxidase acitivity, promotes atherogenesis whilst decreased superoxide production 215 
leads to a reduction of atherosclerosis [5, 33, 34]. Furthermore, macrophage-specific 216 
expression of mitochondrial-targeted catalase decreases both mitochondrial oxidative 217 
stress and plaque formation [35]. The ectopic expression of catalase also decreases 218 
NFκβ pathway activation and plaque monocyte infiltration [35], again highlighting the 219 
link between mitochondria, ROS and inflammation. 220 
 221 
Overall the evidence from human and mouse studies suggests that oxidative stress 222 
is present and promotes atherosclerosis. However, whether increased ROS mediates 223 
the effects of mtDNA damage is more uncertain. For example, when first described 224 
mutator mice showed no evidence of increased oxidative stress despite extensive 225 
mtDNA lesions [16, 36]. In contrast, later work showed that reducing mitochondrial 226 
ROS with over-expression of mitochondrial-targeted catalase partially rescued a 227 
cardiomyopathy phenotype [37]. One of the difficulties in the field has been the ability 228 
to assess ROS accurately in vivo, and this may account for differing findings in 229 
published studies. The conventional methods of measuring ROS rely on redox-230 
sensitive dyes that are taken up into the cytoplasm or mitochondria. In 231 
 11 
atherosclerosis these dyes can lack both sensitivity and specificity, in part because of 232 
autofluorescence of both the normal vessel wall and plaque components. In contrast, 233 
the mitochondria-targeted ratiometric probe MitoB accumulates within mitochondria, 234 
where it reacts with hydrogen peroxide to form MitoP [38]. Quantifying the 235 
mitoP/mitoB ratio enables measurement of mitochondrial hydrogen peroxide. MitoB 236 
showed no difference in mitochondrial ROS levels in young mutator mice [39] even 237 
when crossed with apolipoprotein E deficient mice [6]. This suggested that mtDNA 238 
damage and mitochondrial dysfunction do not necessarily lead to increased ROS, but 239 
can still promote atherosclerosis. The finding may explain why in clinical studies 240 
antioxidants such as Vitamins C and E fail to reduce events in atherosclerosis, and a 241 
mitochondria-targeted antioxidant did not affect plaque burden in mice [40].  242 
 243 
Collectively, recent studies indicate that prolonged mtDNA damage and dysfunction 244 
may lead to increased oxidative stress [39]. However, ROS-independent 245 
mechanisms also link mtDNA damage and mitochondrial dysfunction with 246 
atherosclerosis. We may therefore need to consider the timing of anti-oxidant 247 
therapies and to target other aspects of mitochondrial dysfunction when developing 248 
treatments for atherosclerosis.  249 
 250 
Cell death, mtDNA damage and atherosclerosis 251 
mtDNA damage not only promotes inflammation and oxidative stress but also 252 
regulates cell death, which has a well-recognised role in atherogenesis. Selective 253 
VSMC apoptosis accelerates plaque growth [4], and promotes thinning of the fibrous 254 
cap, an increase of the necrotic core, and intimal inflammation - all features of the 255 
vulnerable plaque [41]. Monocyte/macrophage apoptosis also affects plaque 256 
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composition and development, with suppression of circulating monocytes reducing 257 
atherogenesis [42], but macrophage apoptosis leading to an expansion of the 258 
necrotic core [43].  259 
 260 
Cell death therefore influences plaque development and mitochondria have an 261 
essential role in the intrinsic apoptotic pathway (Figure 3). Signalling of apoptotic 262 
stimuli converges on the Bcl2 proteins Bax and Bak, which form pores leading to 263 
mitochondrial outer membrane permeabilisation. The release of pro-apoptotic factors 264 
such as cytochrome c leads to activation of the cascade that executes apoptosis [44]. 265 
Cytochrome c release may also result from opening of the MPTP. MPTP opening 266 
leads to equilibration of the ions between the mitochondrial matrix and cytosol, 267 
leading to mitochondrial swelling. Pressure is exerted on the outer mitochondrial 268 
membrane that then ruptures, releasing cytochrome c, which binds with the adapter 269 
protein apaf 1 and activates caspases. MPTP is an important regulator of cell death 270 
as transient opening may allow apoptosis, whilst prolonged opening results in 271 
collapse of oxidative phosphorylation and necrosis [45].  272 
 273 
mtDNA damage and dysfunction result in decreased ATP and mitochondrial 274 
membrane potential, both factors that increase MPTP opening and apoptosis. 275 
Indeed, several studies have identified increased apoptosis in mutator mice [16, 18], 276 
and we found increased apoptosis in their plaques in vivo, and in both VSMCs and 277 
monocytes in vitro [6]. mtDNA damage and dysfunction therefore increase apoptosis 278 
and thus can promote atherosclerosis. 279 
 280 
 13 
Although there is evidence that mtDNA defects promote apoptosis, the exact 281 
mechanisms of how mitochondria regulate cell death remain unclear. One particular 282 
area of debate is the composition and regulation of the MPTP, with only cyclophilin D 283 
confirmed as an essential component [46] Although the voltage-dependent anion 284 
channel (VDAC) and the adenine nucleotide transporter (ANT) were proposed to 285 
form the MPTP, genetic studies have shown that they are not essential components 286 
[47]. Recent work now suggests that dimers of the ATP synthase form the MPTP 287 
[48], and others have shown novel roles for p53 and Bax in triggering MPTP-288 
mediated necrosis [49, 50]. As p53 and Bax are well-recognised pro-apoptotic 289 
signals, regulation of MPTP is clearly important for determining the mode of cell 290 
death (Figure 3). 291 
 292 
Mitochondrial dynamics 293 
Mitochondria form a dynamic network within the cell, undergoing constant fusion and 294 
fission. Mitochondrial dynamics not only regulate mitochondrial morphology and 295 
number, but are also a determinant of cell death [51]. Mitochondrial fission occurs in 296 
apoptosis, with loss of mitochondrial membrane potential facilitating release of 297 
cytochrome c. Although fission is largely mediated by the GTPase dynamin-1-like 298 
protein (Drp1), Drp1-independent mechanisms may also exist [52]. Conversely, optic 299 
atrophy 1(Opa1) is an inner mitochondrial membrane fusion protein with anti-300 
apoptotic effects. Opa1 controls mitochondrial cristae shape, and reduces 301 
cytochrome c release by keeping the cristae junctions tight during apoptosis [53]. 302 
These effects are proposed to be independent of mitochondrial fusion, and indeed 303 
the relationship between fusion and cell death is more uncertain. Inhibiting fission 304 
leads to a fused phenotype, and decreased MPTP opening and subsequent cell 305 
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death in cardiomyocytes [54]. In contrast, recent work shows that inhibiting fission 306 
potentiates MPTP opening in fibroblasts [49]. The role of mitochondrial dynamics in 307 
regulating cell death is therefore complex and remains to be fully understood.  308 
 309 
mtDNA damage, altered metabolism and atherosclerosis 310 
Atherosclerosis is not only promoted by local effects on plaque cells, but also by 311 
systemic metabolic effects, including hypercholesterolaemia, diabetes and 312 
hypertension. It is increasingly recognised that mtDNA defects not only affect 313 
mitochondrial and cellular function but also whole organism metabolism [55]. 314 
Mitochondria generate ATP using substrates from the Krebs cycle that can be 315 
derived from lipids, carbohydrates and proteins. Mitochondria therefore coordinate 316 
metabolism and energy production, with energy levels signalled by the AMP/ATP 317 
ratio. In mitochondrial dysfunction AMP/ATP increases, activating AMP-activated 318 
protein kinase (AMPK), which has multiple effects including inhibition of 319 
gluconeogenesis and adipogenesis [56]. Indeed, mutator mice show decreased body 320 
weight and reduced subcutaneous fat [15].  321 
 322 
Recent studies have shown that mitochondrial dysfunction also disrupts fat 323 
metabolism through fibroblast growth factor 21 (FGF21), a hormone that regulates 324 
lipolysis [57]. Human and mouse muscle fibres that have defective oxidative 325 
phosphorylation release FGF21, leading to mobilisation of lipids from adipose tissue 326 
[58, 59]. Such lipolysis is associated with decreased fat mass, but increased serum 327 
glycerol and free fatty acids [60]. Similarly, mutator mice that were also deficient for 328 
apolipoprotein E showed reduced fat mass but exaggerated pro-atherogenic 329 




Protection against mtDNA damage and potential therapeutics 333 
Taken together, current evidence indicates that mtDNA damage and dysfunction can 334 
promote atherosclerosis through inflammation, oxidative stress, cell death and 335 
altered lipid metabolism. Protecting against mtDNA damage and dysfunction is 336 
therefore a potential therapeutic strategy, and could utilise the multiple processes 337 
that already exist to protect against mtDNA damage. First line is the mitochondrial 338 
anti-oxidant system that scavenges ROS generated by the respiratory chain. Matrix 339 
and inter-membrane space superoxide dismutases convert superoxide (O2
•–) into 340 
hydrogen peroxide (H2O2). H2O2 is then safely reduced to water by glutathione 341 
peroxidase or catalase (Figure 1). However, the balance between ROS generation 342 
and antioxidant activity determines the mitochondrial oxidative status, and mtDNA 343 
damage may still occur. 344 
 345 
If mitochondrial damage develops during disease, then mitochondrial dynamics can 346 
have a protective effect. For example, mitochondrial fusion allows mtDNA and 347 
substrates to be shared, alleviating the effects of mtDNA damage or substrate 348 
deprivation [61]. Indeed, multiple defects in mtDNA copy number, mitochondrial 349 
function and tissue function are observed when mitochondrial fusion is impaired [61].  350 
Finally, if the levels of mtDNA damage and dysfunction overwhelm the protective 351 
anti-oxidant and fusion processes, mitophagy is an important determinant of 352 
mitochondrial health. Mitophagy is a mechanism by which dysfunctional mitochondria 353 
are cleared from the cell by lysosomal degradation and components recycled ready 354 
for further use. To signal mitophagy dysfunctional mitochondria accumulate PTEN-355 
induced putative kinase 1 (Pink1) on the outer mitochondrial membrane. Parkin, a 356 
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component of the E3 ubiquitin ligase complex, is susbsequently recruited by 357 
mitofusin 2 and ubiquitinates multiple proteins, including VDAC, to mark mitochondria 358 
for autophagic degradation [62-64]. All of these pathways may be useful therapeutic 359 
targets in the treatment of atherosclerosis.  360 
 361 
Concluding Remarks and Future Perspectives 362 
The dynamic mitochondrial network generates ATP, the universal fuel for metabolic 363 
processes. Mitochondria are thus vital for eukaryotic function, yet they retain some 364 
independence, with their own genome and time-scale of replication. Mitochondria are 365 
also critical regulators of cell death, inflammation, generation of ROS, and 366 
metabolism. Recent evidence indicates that mtDNA damage and dysfunction disrupts 367 
these processes and can promote atherosclerosis. However many questions remain 368 
that need to be answered by future studies (Box 1). Although ROS are associated 369 
with both atherosclerosis and mtDNA damage, whether there are other significant 370 
causes of mitochondrial dysfunction in atherosclerosis remains to be seen. Future 371 
work may also clarify the mechanisms linking mitochondrial dysfunction and 372 
inflammation. For example, are there other mitochondrial-derived ligands for the 373 
NLRP3 inflammasome in addition to mtDNA and cardiolipin, and does mitochondrial 374 
dysfunction promotes other inflammasome-independent pathways? We also do not 375 
know what determines whether mtDNA damage and dysfunction leads to oxidative 376 
stress. Finally, it is critical to determine whether protecting against mtDNA damage 377 
and mitochondrial dysfunction reduces atherogenesis and/or promotes plaque 378 
stability in atherosclerosis. 379 
  380 
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Glossary box 536 
 537 
Apoptosis: a process of programmed cell death, involving caspase activation and 538 
degradation of cellular components. The intrinsic apoptotic pathway converges on 539 
the proteins Bax and Bak that form pores which mediate mitochondrial outer 540 
membrane permeabilisation (MOMP). MOMP releases pro-apoptotic factors such as 541 
cytochrome c.  542 
Mitochondrial DNA (mtDNA): a circular loop of DNA found in the mitochondrial 543 
matrix. mtDNA encodes 13 of the respiratory chain polypeptides and tRNAs and 544 
rRNAs. 545 
Mitochondrial dynamics: mitochondria constantly undergo fission and fusion. 546 
Fission is mediated by Drp-1. Mitochondrial fusion is mediated by mitofusins 1 and 2 547 
(located on the outer mitochondrial membrane) and Opa-1, found on the inner 548 
mitochondrial membrane. 549 
Mitochondrial Permeability Transition Pore (MPTP): A pore formed on the inner 550 
mitochondrial membrane that is regulated by ciclosporin A, and which is permeable 551 
to small solutes and ions. MPTP opening is increased in conditions of mitochondrial 552 
dysfunction- decreased mitochondrial membrane potential, increased ROS, 553 
decreased ATP, and promotes cell death. 554 
Mitophagy: process where dysfunctional mitochondria are recognised and targeted 555 
to the autophagy pathway for degradation.  556 
Mutator mouse: a mouse model of mtDNA disease that has multiple mutations and 557 
deletions in the mtDNA.  558 
NLRP3 inflammasome: a complex formed from NLRP3, ASC adapter protein and 559 
caspase 1. The active NLRP3 inflammasome activates caspase 1, which cleaves 560 
pro-Il1β and pro-Il18 into their mature forms. 561 
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 562 
Nuclear Factor Kappa Beta (NFκβ): a transcription factor that regulates many 563 
genes involved in the immune response, including cytokines and growth factors.  564 
Reactive oxygen species (ROS): reactive oxygen species, primarily superoxide, 565 
hydrogen peroxide and the hydroxyl radical. ROS are produced by the respiratory 566 
chain when electrons leak away, predominantly at complexes I and III, leading to the 567 
partial reduction of oxygen.  568 
Respiratory chain: is composed of respiratory complexes I-IV that mediate electron 569 
transfer, reducing oxygen to water. 570 
Vascular smooth muscle cell (VSMC): cells present in the atherosclerotic plaque 571 
that secrete the extracellular matrix cap. The cap stabilises the plaque.  572 
 26 
Box 1. Outstanding questions  573 
 Apart from mtDNA damage, are there other factors that promote mitochondrial 574 
dysfunction and atherosclerosis? 575 
 Are there other pathways linking mitochondrial dysfunction and inflammation. Do 576 
other mitochondrial-derived ligands for the NLRP3 exist? Are there additional 577 
inflammasome independent pathways?  578 
 What determines whether mtDNA damage and dysfunction leads to oxidative 579 
stress? 580 
 Does protecting against mtDNA damage and mitochondrial dysfunction decrease 581 
atherosclerosis? 582 
 583 
  584 
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Figure legends 585 
Figure 1. Mitochondrial respiratory chain 586 
The electron transport chain receives electrons (e-) from NADH and FADH2 and 587 
mediates electron transfer from complex I to complex IV, via ubiquinone (Ub) and 588 
cytochrome c (C). At complex IV electrons reduce molecular oxygen to form water. 589 
As the electrons are transported a proton (H+) gradient is created across the inner 590 
mitochondrial membrane (IMM). Complex V (ATP synthase) uses this gradient to 591 
convert ADP to ATP. As a by-product of the respiratory chain reactive oxygen 592 
species (ROS) are generated. Superoxide (O2•–) is formed at complexes I and III, 593 
and is dismutated to hydrogen peroxide (H2O2) by matrix manganese superoxide 594 
dismutase (MnSOD). H2O2 can then be safely reduced to water by catalase or 595 
glutathione peroxidase (GPX).  596 
 597 
Figure 2. Mechanisms linking mitochondrial dysfunction and inflammation 598 
The NLRP3 inflammasome is a multi-protein complex composed of NLRP3, the 599 
adapter protein ASC and pro-caspase 1 (pro casp 1). Once activated caspase 1 600 
cleaves pro-IL1β into its mature form. Dysfunctional mitochondrial generate reactive 601 
oxygen species (ROS), externalize cardiolipin (CL) and release mitochondrial DNA 602 
(mtDNA), all of which can activate NLRP3. NAD/NADH levels are also decreased, 603 
leading to decreased sirtuin 2 activity and the accumulation of α-acetylated tubulin 604 
that promotes NLRP3 and ASC colocalisation. mtDNA also has significant amounts 605 
of unmethylated DNA as CpG islands, which activate NFκβ signaling and increased 606 




Figure 3 Mitochondrial regulation of cell death 610 
Apoptotic stimuli converge on Bax and Bak, which oligomerise to form pores that 611 
mediate mitochondrial outer membrane permeabilisation. Cytochrome c is released 612 
from the intermembrane space and binds with the adapter protein Apaf-1 to activate 613 
caspase 9. The ensuing caspase cascade leads to apoptosis. Apoptosis can be 614 
amplified by opening of the mitochondrial permeability transition pore (MPTP), which 615 
allows entry of water and solutes (<1.5 kDa). Mitochondrial swelling leads to rupture 616 
of the outer mitochondrial membrane and cytochrome c release; however prolonged 617 
MPTP opening results in collapse of oxidative phosphorylation and necrosis. MPTP 618 
opening is increased in conditions associated with mitochondrial dysfunction 619 
including increased reactive oxygen species and depletion of ATP. The pro-apoptotic 620 
signals Bax and p53 also promote MPTP opening.  621 
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